NUCB2 and Obesity: We postulate that increased expression of Nesfatin-1 is responsible for reduced weight gain in HFDO and HFDM groups and the anti-obesity and intestinal protective effects of MESK are due to increased expression of Nesfatin-1 caused by MESK (Figure 18).